• Latest Posts

Mage Biologics created to develop oral antibody therapy for ulcerative colitis

Lilly boosts obesity portfolio with Versanis Bio acquisition

UCB myasthenia gravis drug given FDA approval 

Sanofi drug reduces disease activity in relapsing MS

TORL BioTherapeutics launches with $158M to target cancer

Calida Therapeutics launches to tackle thrombo-inflammatory disorders


Purple Biotech sees positive results from cancer study

Disc Medicine raises $62.5M for hematology programs

Janssen reports positive topline phase 2 HDFN results

EMA accepts Marketing Authorization Application for lecanemab to treat early Alzheimer’s disease

Dupixent gets EU nod for children with severe atopic dermatitis

Positive Dupixent eosinophilic esophagitis phase 3 results